Se-(Methyl)selenocysteine hydrochloride
SIGMA/M6680 - ≥95% (TLC)
CAS Number: 863394-07-4
Empirical Formula (Hill Notation): C4H9NO2Se · HCl
Molecular Weight: 218.54
MDL Number: MFCD03412450
Linear Formula: C4H9NO2Se · HCl
Product Type: Chemical
| assay | ≥95% (TLC) |
| InChI | 1S/C4H9NO2Se.ClH/c1-8-2-3 |
| InChI key | JMPVTFHGWJDSDV-DFWYDOINSA |
| Quality Level | 200 ![]() |
| SMILES string | Cl.C[Se]C[C@H](N)C(O)=O |
| storage temp. | −20°C |
| Application: | Se-(Methyl) selenocysteine hydrochloride has been used as a standard in fluorescence-XANES (X-ray absorption near-edge spectroscopy) imaging. |
| Biochem/physiol Actions: | Se-(Methyl)selenocysteine is a chemopreventive agent that blocks cell cycle progression and proliferation of premalignant mammary lesions and induces apoptosis of cancer cell lines in culture. |
| Biochem/physiol Actions: | Selenium (Se)-(Methyl) selenocysteine functions as a potent chemotherapeutic agent for human breast cancer. Enhanced production of methlylselenol from L-Se-methylselenocysteine in vivo alters redox status of cells and oxidatively triggers cellular apoptosis. It is implicated in inhibition of mammary tumor formation in rats. |
| General description: | Selenium (Se)-(Methyl) selenocysteine (MeSeCys) is a methylated product of selenocysteine, this reaction is catalyzed by selenocysteine methyltransferase (SMT) in Astragalus bisulcatus. |
| Packaging: | 100 mg in poly bottle |
| Symbol | ![]() ![]() GHS06,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H301 + H331 - H373 - H410 |
| Precautionary statements | P260 - P264 - P273 - P301 + P310 - P304 + P340 + P311 - P314 |
| Hazard Codes | T,N |
| Risk Statements | 23/25-33-50/53 |
| Safety Statements | 20/21-28-45-60-61 |
| RIDADR | UN 3283 6.1 / PGII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (TLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352209 |




